Differential effects of selective frankincense (Ru Xiang) essential oil versus non-selective sandalwood (Tan Xiang) essential oil on cultured bladder cancer cells: A microarray and bioinformatics study

Chinese Medicine (United Kingdom)

Volumn 9, Issue 1, 2014, Pages

  Dozmorov, Mikhail G ^a   Yang, Qing ^b   Wu, Weijuan ^b   Wren, Jonathan ^a   Suhail, Mahmoud M ^c   Woolley, Cole L ^d   Young, D G ^d   Fung, Kar Ming ^b,e   Lin, Hsueh Kung ^b,f  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c Dhofar Frankincense Research Plant   (Oman)

^d Young Living Essential Oils   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f University of Oklahoma Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; ESSENTIAL OIL; G PROTEIN COUPLED RECEPTOR; HEAT SHOCK PROTEIN; INTERLEUKIN 6; PROTEIN KINASE;

ARTICLE; BIOINFORMATICS; BLADDER CANCER; BLADDER CANCER CELL LINE; BOSWELLIA SACRA; CANCER CELL; CELL VIABILITY; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDRODISTILLATION; MASS FRAGMENTOGRAPHY; MICROARRAY ANALYSIS; SANTALUM; SANTALUM ALBUM;

EID: 84904034948     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-9-18     Document Type: Article

References (59)

1. Banno N, Akihisa T, Yasukawa K, Tokuda H, Tabata K, Nakamura Y, Nishimura R, Kimura Y, Suzuki T. Anti-inflammatory activities of the triterpene acids from the resin of Boswellia carteri. J Ethnopharmacol 2006, 107:249-253.
2. Langmead L, Rampton DS. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther 2006, 23:341-349.
3. Winking M, Sarikaya S, Rahmanian A, Jodicke A, Boker DK. Boswellic acids inhibit glioma growth: a new treatment option?. J Neurooncol 2000, 46:97-103.
4. Hostanska K, Daum G, Saller R. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res 2002, 22:2853-2862.
5. Huang MT, Badmaev V, Ding Y, Liu Y, Xie JG, Ho CT. Anti-tumor and anti-carcinogenic activities of triterpenoid, β-boswellic acid. Biofactors 2000, 13:225-230.
6. Frank MB, Yang Q, Osban J, Azzarello JT, Saban MR, Saban R, Ashley RA, Welter JC, Fung KM, Lin HK. Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity. BMC Complement Altern Med 2009, 9:6.
7. Suhail MM, Wu W, Cao A, Mondalek FG, Fung KM, Shih PT, Fang YT, Woolley C, Young G, Lin HK. Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells. BMC Complement Altern Med 2011, 11:129.
8. Ni X, Suhail MM, Yang Q, Cao A, Fung KM, Postier RG, Woolley C, Young G, Zhang J, Lin HK. Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model. BMC Complement Altern Med 2012, 12:253.
9. Park YS, Lee JH, Bondar J, Harwalkar JA, Safayhi H, Golubic M. Cytotoxic action of acetyl-11-keto-β-boswellic acid (AKBA) on meningioma cells. Planta Med 2002, 68:397-401.
10. Shao Y, Ho CT, Chin CK, Badmaev V, Ma W, Huang MT. Inhibitory activity of boswellic acids from Boswellia serrata against human leukemia HL-60 cells in culture. Planta Med 1998, 64:328-331.
11. Liu JJ, Nilsson A, Oredsson S, Badmaev V, Duan RD. Keto- and acetyl-keto-boswellic acids inhibit proliferation and induce apoptosis in Hep G2 cells via a caspase-8 dependent pathway. Int J Mol Med 2002, 10:501-505.
12. Zhao W, Entschladen F, Liu H, Niggemann B, Fang Q, Zaenker KS, Han R. Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detect Prev 2003, 27:67-75.
13. Liu JJ, Nilsson A, Oredsson S, Badmaev V, Zhao WZ, Duan RD. Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells. Carcinogenesis 2002, 23:2087-2093.
14. Pang X, Yi Z, Zhang X, Sung B, Qu W, Lian X, Aggarwal BB, Liu M. Acetyl-11-keto-β-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Cancer Res 2009, 69:5893-5900.
15. Lu M, Xia L, Hua H, Jing Y. Acetyl-keto-β-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cells. Cancer Res 2008, 68:1180-1186.
16. Syrovets T, Gschwend JE, Buchele B, Laumonnier Y, Zugmaier W, Genze F, Simmet T. Inhibition of IκB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. J Biol Chem 2005, 280:6170-6180.
17. Lin HK, Suhail MM, Fung KM, Woolley CL, Young DG. Extraction of biologically active compounds by hydrodistillation of species gum resins for anti-cancer therapy. OA Altern Med 2013, 1:4.
18. Moy RL, Levenson C, So JJ, Rock JA. Single-center, open-label study of a proprietary topical 0.5% salicylic acid-based treatment regimen containing sandalwood oil in adolescents and adults with mild to moderate acne. J Drugs Dermatol 2012, 11:1403-1408.
19. Ohmori A, Shinomiya K, Utsu Y, Tokunaga S, Hasegawa Y, Kamei C. Effect of santalol on the sleep-wake cycle in sleep-disturbed rats. Nihon Shinkei Seishin Yakurigaku Zasshi 2007, 27:167-171.
20. Misra BB, Dey S. Comparative phytochemical analysis and antibacterial efficacy of in vitro and in vivo extracts from East Indian sandalwood tree (Santalum album L.). Lett Appl Microbiol 2012, 55:476-486.
21. Dwivedi C, Abu-Ghazaleh A. Chemopreventive effects of sandalwood oil on skin papillomas in mice. Eur J Cancer Prev 1997, 6:399-401.
22. Dwivedi C, Zhang Y. Sandalwood oil prevent skin tumour development in CD1 mice. Eur J Cancer Prev 1999, 8:449-455.
23. Stichlmair J, Fair JR. Distillation : principles and practices 1998, New York: Wiley.
24. Woolley CL, Suhail MM, Smith BL, Boren KE, Taylor LC, Schreuder MF, Chai JK, Casabianca H, Haq S, Lin HK, Al-Shahri AA, Al-Hatmi S, Young DG. Chemical differentiation of Boswellia sacra and Boswellia carterii essential oils by gas chromatography and chiral gas chromatography-mass spectrometry. J Chromatogr A 2012, 1261:158-163.
25. OToole C, Price ZH, Ohnuki Y, Unsgaard B. Ultrastructure, karyology and immunology of a cell line originated from a human transitional-cell carcinoma. Br J Cancer 1978, 38:64-76.
26. Petzoldt JL, Leigh IM, Duffy PG, Sexton C, Masters JR. Immortalisation of human urothelial cells. Urol Res 1995, 23:377-380.
27. Dozmorov I, Knowlton N, Tang Y, Centola M. Statistical monitoring of weak spots for improvement of normalization and ratio estimates in microarrays. BMC Bioinformatics 2004, 5:53.
28. Knowlton N, Dozmorov IM, Centola M. Microarray Data Analysis Toolbox (MDAT): for normalization, adjustment and analysis of gene expression data. Bioinformatics 2004, 20:3687-3690.
29. Hua J, Balagurunathan Y, Chen Y, Lowey J, Bittner ML, Xiong Z, Suh E, Dougherty ER. Normalization benefits microarray-based classification. EURASIP J Bioinform Syst Biol 2006, 43056. doi:10.1155/BSB/2006/43056.
30. Gusnanto A, Calza S, Pawitan Y. Identification of differentially expressed genes and false discovery rate in microarray studies. Curr Opin Lipidol 2007, 18:187-193.
31. Dozmorov IM, Centola M, Knowlton N, Tang Y. Mobile classification in microarray experiments. Scand J Immunol 2005, 62(Suppl 1):84-91.
32. Dozmorov I, Centola M. An associative analysis of gene expression array data. Bioinformatics 2003, 19:204-211.
33. Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics 2006, 7:91.
34. Dozmorov I, Knowlton N, Tang Y, Shields A, Pathipvanich P, Jarvis JN, Centola M. Hypervariable genes-experimental error or hidden dynamics. Nucleic Acids Res 2004, 32:e147.
35. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4:3.
36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT Method. Methods 2001, 25:402-408.
37. Howes MJ, Simmonds MS, Kite GC. Evaluation of the quality of sandalwood essential oils by gas chromatography-mass spectrometry. J Chromatogr A 2004, 1028:307-312.
38. Subasinghe U, Gamage M, Hettiarachchi DS. Essential oil content and composition of Indian sandalwood (Santalum album) in Sri Lanka. J Forest Res 2013, 24:127-130.
39. Shellie R, Marriott P, Morrison P. Comprehensive two-dimensional gas chromatography with flame ionization and time-of-flight mass spectrometry detection: qualitative and quantitative analysis of West Australian sandalwood oil. J Chromatogr Sci 2004, 42:417-422.
40. Devary Y, Gottlieb RA, Smeal T, Karin M. The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases. Cell 1992, 71:1081-1091.
41. Quantin B, Breathnach R. Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts. Nature 1988, 334:538-539.
42. Korber B, Mermod N, Hood L, Stroynowski I. Regulation of gene expression by interferons: control of H-2 promoter responses. Science 1988, 239:1302-1306.
43. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991, 1072:129-157.
44. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002, 4:E131-E136.
45. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, Young LS. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem 1999, 274:16085-16096.
46. Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 1988, 55:917-924.
47. Gajate C, Alonso MT, Schimmang T, Mollinedo F. C-Fos is not essential for apoptosis. Biochem Biophys Res Commun 1996, 218:267-272.
48. Jamieson GA, Mayforth RD, Villereal ML, Sukhatme VP. Multiple intracellular pathways induce expression of a zinc-finger encoding gene (EGR1): relationship to activation of the Na/H exchanger. J Cell Physiol 1989, 139:262-268.
49. Hooker CW, Hurlin PJ. Of Myc and Mnt. J Cell Sci 2006, 119:208-216.
50. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998, 282:1497-1501.
51. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000, 408:307-310.
52. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR, Billiar TR. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 2007, 204:2913-2923.
53. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, Zeh HJ, Lotze MT. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010, 29:5299-5310.
54. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
55. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, Nagashima M, Lundh ER, Vijay S, Nitecki D, Morser J, Stern D, Schmidt AM. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995, 270:25752-25761.
56. Kim SW, Lim CM, Kim JB, Shin JH, Lee S, Lee M, Lee JK. Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway. Neurotox Res 2011, 20:159-169.
57. Murias M, Luczak MW, Niepsuj A, Krajka-Kuzniak V, Zielinska-Przyjemska M, Jagodzinski PP, Jager W, Szekeres T, Jodynis-Liebert J. Cytotoxic activity of 3,3',4,4',5,5'-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase. Toxicol In Vitro 2008, 22:1361-1370.
58. Verrax J, Taper H, Buc Calderon P. Targeting cancer cells by an oxidant-based therapy. Curr Mol Pharmacol 2008, 1:80-92.
59. Verrax J, Pedrosa RC, Beck R, Dejeans N, Taper H, Calderon PB. In situ modulation of oxidative stress: a novel and efficient strategy to kill cancer cells. Curr Med Chem 2009, 16:1821-1830.